Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial

European Heart Journal

Volumn 35, Issue 21, 2014, Pages 1411-1420

  Jennings, Catriona ^a   Kotseva, Kornelia ^a   De Bacquer, Dirk ^b   Hoes, Arno ^c   De Velasco, Jose ^d   Brusaferro, Silvio ^e   Mead, Alison ^a   Jones, Jennifer ^a   Tonstad, Serena ^f   Wood, David ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^e UNIVERSITY OF UDINE   (Italy)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

High cardiovascular risk; Preventive cardiology; Smoking cessation

Indexed keywords

ANTIHYPERTENSIVE AGENT; CARBON MONOXIDE; CHOLESTEROL; GLUCOSE; LIPID; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOLOGY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET THERAPY; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PREVALENCE; PREVENTION STUDY; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING CESSATION; VASCULAR DISEASE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DIET; FEMALE; KINESIOTHERAPY; MALE; MIDDLE AGED; MULTICENTER STUDY; NURSING; PROCEDURES; RISK REDUCTION; SMOKING; TREATMENT OUTCOME;

BENZAZEPINES; CARDIOVASCULAR DISEASES; DIET; EXERCISE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINIC AGONISTS; QUINOXALINES; RISK REDUCTION BEHAVIOR; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84901977453     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu051     Document Type: Article

References (45)

1. Services USDoHaH. (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. 2010
2. Edwards R. The problem of tobacco smoking. Br Med J 2011;328:217-219
3. Prescott E,HippeM, Schnohr P,HeinHO,VestboJ. Smoking and riskofmyocardial infarction in women and men: Longitudinal population study. Br Med J 1998;316:1043-1047
4. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, on behalf of EUROASPIRE study Group. EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from twenty two European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-137
5. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, on behalf of EUROASPIRE study Group. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high risk subjects in general practice: Cross-sectional survey in 12 European countries. Eur J Cardiovas Prev Rehabil 2010;17:530-540
6. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori S, Pyorala K, Reiner Z, Ruilope L, Sansk-Mendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans G, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamarano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampoloi S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoff AF, Tokgozoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: Full text. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardio s Prev Rehabil 2007;14(Suppl 2):S1-S113. (Pubitemid 47339826
7. Prochaska J, Prochaska J. A review of multiple heath behaviour change interventions for primary prevention. Am J Lifestyle Med 2011;5:208-221
8. Taylor R, Brown A, Ebrahim S, Joliffe J, Noorani H, Rees K, Skidmore B, Stone JA, ThompsonDR, Oldridge N. Exercise-based rehabilitation for patients with coronary heart disease: Systematic review and meta-Analysis of randomised controlled trials. Am J Med 2004;116:682-692. (Pubitemid 38581114
9. Ebrahim S, Taylor F,Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database Syst Rev 2011;1:CD001561
10. WoodDA, Kotseva K, Jennings C,MeadA, Jones J, Holden A, Connolly S; on behalf of the EuroAction Study Group. EUROACTION: A European Society of Cardiology demonstration project in preventive cardiology. Eur Heart J 2004;6(Suppl J):J3-J15
11. Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O; on behalf of EUROACTION Study Group. Nurse-coordinated multidisciplinary, family-based preventive cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: A paired, cluster-randomised controlled trial. Lancet 2008;371:1999-2012
12. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2008;4:CD001292
13. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;3:CD000146
14. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4:CD006103
15. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: A randomized trial. Circ 2010;121:221-229
16. Ludvig J, Miner B, Eisenberg MJ. Smoking cessation in patients with coronary artery disease. Am Heart J 2005;149:565-572
17. Velicer W, Prochaska JO. A comparison of four self-report smoking cessation outcome measures. Addict Behav 2004;29:51-60. (Pubitemid 37521293
18. Mead A. Pan European Cardiac Prevention and Rehabilitation: Impact on dietary change (doctoral thesis). Imperial College London. 2009
19. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003;348:2599-2608. (Pubitemid 36741587
20. Blair SN, Haskell WL, Ho P, Paffenbarger RS, Vranizan KM, Farquhar JW,Wood PD. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 1985;122:794-804. (Pubitemid 16207346
21. Welk GJ, Differding JA, Thompson RW, Blair SN, Dziura J, Hart P. The utility of the Digi-Walker step counter to assess daily physical activity patterns. Med Sci Sports Exerc 2000;32(suppl):S481
22. Sykes K. Chester Step Test; Resource Pack (Version 3). Cheshire, UK: Chester College of Higher Education; 1998
23. WHO. Measuring Obesity: Classification and Distribution of Anthropometric Data. Copenhagen:World Health Organisation; 1989
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370. (Pubitemid 13098606
25. EuroQoL Group. EuroQoL-A new facility for the measurements of health-related quality of life. Health Policy 1990;16:199-208
26. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: Applications to addictive behaviour. Am Psychol 1992;47:1102-1114
27. MillerW, Rollnick S. Motivational Interviewing. London: Guilford Press; 2002
28. Lycett D, Munafò M, Johnstone E, Murphy M, Aveyard P. Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers. Addiction 2011;106:188-196
29. Aubin H-J, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes. A meta-Analysis. Br Med J 2012;345:e4439. doi:10.1136
30. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine Tob Res 2003;5: 13-26
31. Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: Systematic review and meta-Analysis. Br Med J 2012;344:e2856
32. Singh S, Loke YK, Spangler JG, Furberg CD. Risk of cardiovascular serious adverse events associated with varenicline: A systematic review and meta-Analysis. CMAJ 2011;183:1359-1366
33. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: Meta-Analysis. Br Med J 2008;337:a1344
34. Tudor-Locke C, Bassett DR. How many steps/day are enough?. Preliminary pedometer indices for public health. Sports Med 2004;34:1-8. (Pubitemid 38186940
35. WHO Europe Ed, Cavill N. Physical Activity and Health in Europe: Evidence for Action; London, UK. 2006
36. Dept. of Health UK Ed, Sproston K, Primatesta P. Health Survey for England: Volume 2 Cardiovascular Risk Factors. National Centre for Social Research. Denmark: WHO Publications. 2003
37. Blair SN, Jacobs DR, Powell KE. Relationship between exercise or physical activity and other health behaviors. Public Health Rep 1985;100:172-180. (Pubitemid 15064372
38. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, Simons-Morton D, Mccullough M, Swain J, Steele P, Evans MA, Miller ER, Harsha DW. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med 1997;336:1117-1124
39. Cutler JA, Follman D, Allender PS. Randomized trials of sodium reduction: An overview. Am J Clin Nutr 1997;65(2 suppl):643S-651S.
40. Xin X, He J, Frontini MG, Ogden LG, Oaitse I, Motsamai PK, Whelton PK. Effects of alcohol reduction on blood pressure: A meta-Analysis of randomised controlled trials. Hypertension 2001;38:1112-1117. (Pubitemid 34252815
41. Staessen J, Fagard R, Lijnen P, Amery A. Body weight, sodium intake and blood pressure. J Hypertens 1989;7(Suppl.):S19-S23. (Pubitemid 19099039
42. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: A meta-Analysis of randomised controlled trials. Ann Intern Med 2002;136:493-503. (Pubitemid 34252283
43. Pierce JP, Gilpin A. A minimum 6-month prolonged abstinence should be required for evaluating smoking cessation trials. Nicotine Tob Res 2003;5:151-153. (Pubitemid 36546996
44. Hughes JR, Carpenter MJ, Naud S. Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies?. A systematic review. Nicotine Tob Res 2010;12:756-762
45. Middleton ET. Breath carbonmonoxide as an indication of smoking habit. Chest 2000; 117:758-763. (Pubitemid 30152217.